216 related articles for article (PubMed ID: 17503735)
1. Differential loss of presynaptic dopaminergic markers in Parkinsonian monkeys.
Stephenson DT; Childs MA; Li Q; Carvajal-Gonzalez S; Opsahl A; Tengowski M; Meglasson MD; Merchant K; Emborg ME
Cell Transplant; 2007; 16(3):229-44. PubMed ID: 17503735
[TBL] [Abstract][Full Text] [Related]
2. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties.
Li X; Qi J; Yamaguchi T; Wang HL; Morales M
Brain Struct Funct; 2013 Sep; 218(5):1159-76. PubMed ID: 22926514
[TBL] [Abstract][Full Text] [Related]
4. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO
Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234
[TBL] [Abstract][Full Text] [Related]
5. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.
Haycock JW; Becker L; Ang L; Furukawa Y; Hornykiewicz O; Kish SJ
J Neurochem; 2003 Nov; 87(3):574-85. PubMed ID: 14535941
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of dopaminergic cell markers in the adult zebrafish forebrain.
Yamamoto K; Ruuskanen JO; Wullimann MF; Vernier P
J Comp Neurol; 2011 Feb; 519(3):576-98. PubMed ID: 21192085
[TBL] [Abstract][Full Text] [Related]
7. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
9. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
Sconce MD; Churchill MJ; Greene RE; Meshul CK
Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
[TBL] [Abstract][Full Text] [Related]
10. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.
Masoud ST; Vecchio LM; Bergeron Y; Hossain MM; Nguyen LT; Bermejo MK; Kile B; Sotnikova TD; Siesser WB; Gainetdinov RR; Wightman RM; Caron MG; Richardson JR; Miller GW; Ramsey AJ; Cyr M; Salahpour A
Neurobiol Dis; 2015 Feb; 74():66-75. PubMed ID: 25447236
[TBL] [Abstract][Full Text] [Related]
12. Increased vulnerability to L-DOPA toxicity in dopaminergic neurons From VMAT2 heterozygote knockout mice.
Kariya S; Takahashi N; Hirano M; Ueno S
J Mol Neurosci; 2005; 27(3):277-79. PubMed ID: 16280597
[TBL] [Abstract][Full Text] [Related]
13. Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum.
Caudle WM; Richardson JR; Wang M; Miller GW
Neurotoxicology; 2005 Aug; 26(4):721-728. PubMed ID: 16112329
[TBL] [Abstract][Full Text] [Related]
14. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
[TBL] [Abstract][Full Text] [Related]
15. In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment.
Tian L; Karimi M; Brown CA; Loftin SK; Perlmutter JS
Brain Res; 2014 Jul; 1571():49-60. PubMed ID: 24845719
[TBL] [Abstract][Full Text] [Related]
16. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Jourdain S; Morissette M; Morin N; Di Paolo T
J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487
[TBL] [Abstract][Full Text] [Related]
17. Characterization of A11 neurons projecting to the spinal cord of mice.
Koblinger K; Füzesi T; Ejdrygiewicz J; Krajacic A; Bains JS; Whelan PJ
PLoS One; 2014; 9(10):e109636. PubMed ID: 25343491
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical investigation of dopaminergic terminal markers and caspase-3 activation in the striatum of human methamphetamine users.
Kitamura O; Tokunaga I; Gotohda T; Kubo S
Int J Legal Med; 2007 May; 121(3):163-8. PubMed ID: 16622715
[TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.
Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I
Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
